Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Over the past decade, we have made great advances in the field of multiple sclerosis. Introduction.
Estrogen regulates excitatory amino acid carrier 1 (EAAC1) expression through sphingosine kinase 1 (SphK1) transacting FGFR-mediated ERK signaling in rat C6 astroglial cells.
Effects of Coenzyme Q10 on the ratio of TH1/TH2 in Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis in C57BL/6.
HHV-6-positivity in diseases with demyelination.
Immunization of mice with a peptide derived from the HTLV-1 TAX1BP1 protein induces cross-reactive antibodies against aquaporin 4.
Care Partners and Multiple Sclerosis: Differential Effect on Men and Women.
CCRL2 regulates M1/M2 polarization during EAE recovery phase.
Bowman-Birk inhibitor concentrate suppresses experimental autoimmune neuritis via shifting macrophages from M1 to M2 subtype.
Are cognitive interventions for Multiple Sclerosis effective and feasible?
Dexmedetomidine inhibits inducible nitric oxide synthase in lipopolysaccharide-stimulated microglia by suppression of extracellular signal-regulated kinase.
Autoantibodies against vinculin in patients with chronic inflammatory demyelinating polyneuropathy.
Evaluation of the humoral response against mycobacterial peptides, homologous to MOG35-55, in multiple sclerosis patients.
High-density peptide microarray analysis of IgG autoantibody reactivities in serum and cerebrospinal fluid of multiple sclerosis patients.
Small heat shock proteins are induced during multiple sclerosis lesion development in white but not grey matter.
Longitudinal evidence for anterograde trans-synaptic degeneration after optic neuritis.
Searching for the neural basis of reserve against memory decline: intellectual enrichment linked to larger hippocampal volume in multiple sclerosis.
Immunodetection of oligoclonal bands in serum and CSF of Multiple Sclerosis patients.
A Cross-Sectional Examination of the Associations Between Symptoms, Community Integration, and Mental Health in Multiple Sclerosis.
Correction: Knowledge Retrieval from PubMed Abstracts and Electronic Medical Records with the Multiple Sclerosis Ontology.
Longitudinal Functional Data Analysis.
A competitive advantage by neonatally engrafted human glial progenitors yields mice whose brains are chimeric for human glia.
Anti-aquaporin-4 autoantibodies in systemic lupus erythematosus persist for years and induce astrocytic cytotoxicity but not CNS disease.
[Multiple sclerosis and microRNA].
The conundrum of interferon-β non-responsiveness in relapsing-remitting multiple sclerosis.
Low quality of life and psychological wellbeing contrast with moderate perceived burden in carers of people with severe multiple sclerosis.
Pages
« first
‹ previous
…
631
632
633
634
635
636
637
638
639
…
next ›
last »